Litcius/Paper detail

FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer

Libin Ma, Huadong He, Kang Jiang, Peiwu Jiang, Han He, Shengjia Feng, Kean Chen, Jia Shao, Gang Deng

2020Aging26 citationsDOIOpen Access PDF

Abstract

. FAM46C inhibited cell proliferation and cell cycle progression and induced apoptosis via the PTEN/AKT signaling pathway. FAM46C promoted PTEN expression through inhibiting PTEN ubiquitination. The prostate cancer cells and patient-derived xenograft (PDX) mice with high-FAM46C-expressing demonstrated an enhanced chemosensitivity to docetaxel. These findings suggest that FAM46C control cell proliferation, cell cycle and apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity of prostate cancer. Modulation of their levels may offer a new approach for improving anti-tumor efficacy for chemotherapeutic agents in prostate cancer.

Topics & Concepts

DU145PTENCancer researchCell growthProstate cancerCarcinogenesisCell cyclePI3K/AKT/mTOR pathwayProtein kinase BChemistryCancerApoptosisSignal transductionBiologyCell biologyInternal medicineMedicineLNCaPBiochemistryProstate Cancer Treatment and ResearchUbiquitin and proteasome pathwaysCancer, Lipids, and Metabolism
FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer | Litcius